PHARMAC Places Temporary Dispensing Limits On All Funded Community Medicines

Published: Thu 26 Mar 2020 01:30 PM
PHARMAC is placing temporary dispensing limits on all funded community medicines from Friday 27 March 2020.
Changes will be made to the Pharmaceutical Schedule, which is a list of the prescription medicines and therapeutic products subsidised by the Government, restricting the dispensing of funded medicines to just one month's supply at a time. The change is effective from midnight tonight, 26 March 2020.
“This means that from tomorrow (Friday) community pharmacists will be required to limit dispensing of all funded medicines to one month's supply or three-months for oral contraceptives,” explains PHARMAC’s Chief Executive Sarah Fitt.
Despite there being no significant medicine shortages in New Zealand, stockpiling is putting a major strain on supply chains. Unlike supermarkets, also under pressure from stockpiling but able to re-stock from New Zealand manufacturers, medicines are mostly sourced from overseas suppliers and the ability to re-stock quickly is very limited.
“We are making this change to ensure that remaining medicines stocks in wholesalers, distributors and community pharmacies are appropriately managed. We need to ensure that every New Zealander will continue to have access to the medicines they need and that vulnerable communities don’t miss out.
“We do not make this decision lightly, as we know this means people who are in isolation will potentially have to visit pharmacies more often. However, despite messages to prescribers, pharmacies and the general public, stockpiling behaviour has not slowed down. This is putting the fair and equitable distribution of medicines at risk,” says Ms Fitt.
To support social distancing, pharmacists are able to make exceptions to dispense up to three months’ supply for certain people, specifically those with mobility issues, those who live rurally, those who are immunocompromised and the elderly. People are also able to have their prescriptions picked up for them by others.
This change is consistent with steps taken in Australia. There are no changes to the way prescriptions are written, and people won’t need to visit their GP or prescriber more frequently. It also doesn’t change how much they pay for their standard prescription.
The impact of COVID-19 is likely to have global implications for medicine manufacture and supply chains for the remainder of 2020 and potentially beyond. PHARMAC will continue to monitor the situation carefully to ensure that our healthcare providers – both in the community and in hospitals – have the medicines and medical devices they need.

Next in Business, Science, and Tech

Funding For R&D; In New Zealand – Expert Reaction
By: Science Media Centre
COVID-19: NZ Joins Global Initiative Keeping Ports Open And Freight Moving
By: Maritime New Zealand
National Backs Businesses With $10k JobStart
By: New Zealand National Party
Government Exempts Some Home Improvements From Costly Consents
By: New Zealand Government
The New Zealand Herald Named Newspaper Of The Year, Website Of The Year At Voyager Media Awards
By: New Zealand Media and Entertainment
ASB Takes The Lead Again With New Low Home Loan Interest Rate
By: ASB Bank
The Problems With Testing And Case Statistics For Covid-19
By: Nathan Hoturoa Gray
Fletcher Building to lay off 1000 staff in New Zealand
Driving prompt payments to small businesses
By: New Zealand Government
On Why We Should Legally Protect The Right To Work From Home
By: Gordon Campbell
Supporting Kiwi businesses to resolve rent disputes
By: New Zealand Government
Understanding 5G Concerns – Expert Q&A;
By: Science Media Centre
Record Monthly Surplus As Imports Dive
By: Statistics New Zealand
Bar reopening night 'much, much quieter'
New Zealand’s population passes 5 million
By: Statistics New Zealand
View as: DESKTOP | MOBILEWe're in BETA! Send Feedback © Scoop Media